2005
DOI: 10.1161/01.str.0000149624.87661.18
|View full text |Cite
|
Sign up to set email alerts
|

Combining Insulin-Like Growth Factor Derivatives Plus Caffeinol Produces Robust Neuroprotection After Stroke in Rats

Abstract: Background and Purpose-Insulin-like growth factor-1 (IGF-1) and caffeinol are both neuroprotective and probably have different mechanisms of action; therefore, they may be more effective in combination. Methods-We tested the N-terminal tripeptide of IGF-1, Gly-Pro-Glu (GPE), and its analogue, G2MePE, alone and with caffeinol in a rat middle cerebral artery (MCA) suture occlusion model. We randomly assigned rats to 6 groups of 8 to 12 animals: (1) control; (2) GPE, 3 mg/kg per hour; (3) G2MePE, 0.3 mg/kg per ho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(29 citation statements)
references
References 30 publications
1
28
0
Order By: Relevance
“…Consistent with the present study Bickerdike and colleagues (2009) reported that continuous intravenous infusion of G-2MePE reduces the infarct size after endothelin1 (ET1) induced middle cerebral artery vasoconstriction in rats (Bickerdike et al , 2009). Zhao et al (2005) demonstrated that G-2MePE offers effective neuroprotection by reducing neuronal deficit scores at a 10 times lower dose compared to GPE, when treated in combination with caffeinol (Zhao et al , 2005).…”
Section: Discussionsupporting
confidence: 89%
“…Consistent with the present study Bickerdike and colleagues (2009) reported that continuous intravenous infusion of G-2MePE reduces the infarct size after endothelin1 (ET1) induced middle cerebral artery vasoconstriction in rats (Bickerdike et al , 2009). Zhao et al (2005) demonstrated that G-2MePE offers effective neuroprotection by reducing neuronal deficit scores at a 10 times lower dose compared to GPE, when treated in combination with caffeinol (Zhao et al , 2005).…”
Section: Discussionsupporting
confidence: 89%
“…Adenosine, a ubiquitous neuromodulator, plays a key role in these changes by accumulating both during wakefulness and in response to ischemia, hypoxia, excitotoxicity, inflammation, and other types of TBI [31]. Interestingly, an agent that has significant effect on adenosine neurochemistry, caffeine, has also been demonstrated to exert neuroprotective effects after stroke [32] and other neurologic conditions [33][34]. The fact that one study found neuroprotective effects of caffeine when given chronically but not acutely [34] suggests that acute elevation of adenosine as seen with 24 h of SD may but protective, while longer duration SD may be detrimental to brain function.…”
Section: Discussionmentioning
confidence: 99%
“…Another group studied the N-terminal tripeptide of IGF-1, Gly-Pro-Glu (GPE). 33 GPE (3 mg/kg/h), started 75 minutes after MCAO and continued for three days, improved the neurological disability score and reduced cortical infarct size by 45%. Studies on intranasally administered IGF-1 in stroke are described later in this review.…”
Section: Igf-1mentioning
confidence: 96%